An ETF To Invest In Like Billionaire Fund Manager Ray Dalio
Ray Dalio, founder and co-chief Investment Officer of Bridgewater Associates, is one of the most widely followed investors worldwide. His strategy mainly relies on big-picture long-term...
-
-
Market Updates: Markets Mixed, Brent Oil Down, ZAR Weakens Against Dollar
South Africa Market Review South African markets closed in the green yesterday, buoyed by broad based gains in real estate and retail sector stocks. Real estate companies, Dipula Income Fund...
-
3 Recession-Proof Stocks To Protect Your Portfolio From Fed-Induced Turmoil
Fed's expected aggressive tightening to contain soaring inflation, has many worrying about a possible recession. Three companies to protect your portfolio due to strong fundamentals,...
-
Warren Buffett Keeps Outperforming Markets; Replicate His Strategy With This ETF
Wall Street keenly follows Warren Buffett’s investment strategy. Each quarter, Berkshire Hathaway (NYSE:BRKa) (NYSE:BRKb), where Buffett is the CEO, discloses current holdings to...
-
3 Vanguard ETFs For Boosting Portfolio Diversification
Vanguard exchange-traded funds (ETFs) are extremely popular among retail investors. In terms of assets under management, this fund manager is one of the most important ETF providers...
-
2 Value ETFs Offering Long-Term Opportunities As Markets Slide
Bear markets often create opportunities for seasoned investors as declines in share prices lead to new value investment options. So far this year, the S&P 500 and the NASDAQ 100 have...
-
FDA Limits J&J's COVID-19 Vaccine Over Blood Clot Risk
FDA Limits J&J's COVID-19 Vaccine Over Blood Clot Risk The Food and Drug Administration (FDA) on Thursday strictly limited who can receive Johnson & Johnson's Covid-19 vaccine due to a rare...
-
Worried About The Fed Rate Decision? 2 ETFs To Generate Returns After The Hike
All eyes are on the Federal Reserve's decision due out later today. Analysts agree that the central bank is increasingly concerned about inflation and thus will work on reducing the supply...
-
Markets Opened Green, Brent Price Goes Up, SA Rand Decreased
South Africa Market Review South African markets closed in the green on Friday, buoyed by broad-based gains in mining sector stocks. Diversified miners, African Rainbow Minerals (JO:ARIJ),...
-
2 ETFs To Diversify Portfolios If Indices Descend Into A Bear Market
The year-to-date broad market sell-off gathered pace in April, as US indexes recorded their worst monthly performance since the pandemic-driven crash of March 2020. The NASDAQ underperformed...
-
Johnson & Johnson: Solid Dividend Hike, Fairly Valued
Johnson & Johnson (JNJ) specializes in the research, development, manufacturing, and sale of a wide range of products in the health care sector. The company’s operations can be divided into...
-
Johnson & Johnson: Q1 Earnings Offer Another Reason Why Stock Is A Long-Term Buy
There's a simple, enduring case for Johnson & Johnson (NYSE:JNJ) stock. Globally, people are living longer and getting more and better access to healthcare. That trend is going to...
-
Stream Dream Gets Murky
Market Scorecard Yesterday, US stocks gained in a broad-based rally. The markets these days are like a box of Quality Street chocolates - you never know what you are going to get until you...
-
Johnson & Johnson’s Mixed Earnings Report Prompts Volatile Swings
For drugmaker and consumer products leader Johnson & Johnson (JNJ), the premarket proved unsettled ground after announcing quarterly earnings. Losses hit over 3% despite a mixed-bag report,...
-
J&J Beats On Q1 Earnings, Suspends COVID Jab Sales View
Johnson & Johnson’s first-quarter 2022 earnings came in at $2.67 per share.
-
Keep An Eye On JNJ Today
Johnson & Johnson is reporting 1Q22 earnings in a couple of hours.
-
J&J To Set The Tone For Pharma Sector's Q1 Earnings
We expect Johnson & Johnson to beat expectations when it reports first-quarter 2022 results on Apr 19, before the market open.
-
2 ETFs For Investing Tax Returns In Order To Create Future Wealth
April brings an array events worth noting. Spring generally begins to ramp up and on Wall Street a new earnings season starts. As well, for millions of Americans, mid-April is the filing...
-
Week Ahead: Defensive Stocks To Keep Outperforming As Inflation, Geopolitics Loom
Technology sector continues to underperform Fear continues to outweigh greed Both sides of the Fed inflation argument bearish for markets Investors await earnings in hopes of positive...
-
US And European Releases Gain Further Momentum Next Week
Locally, we expect the following releases next week: {{erl-50103||PSG Group is scheduled to publish FY22 results. Investors are looking forward to an update from management following the...
-
The Reliable Johnsons
Market Scorecard US markets retreated yesterday after the Federal Reserve outlined plans to shrink its balance sheet by more than $1 trillion a year. This is on top of hiking interest rates,...
-
2 ETFs For Weathering Growing Recession Risks
Wall Street is debating whether a recession or a significant downturn could be on the horizon for the US and the global economy. Recently, Goldman Sachs suggested that the odds of such an...
-
2 Low Volatility ETFs For A Defensive Approach To Equity Investing
Wall Street has been on high alert in recent months as an array of headwinds has roiled investors—and markets. For starters, following the interest rate hike of March 16, the Federal...
-
Retirement Planning: 3 Safe Dividend-Paying Stocks For Fixed-Income Investors
If your goal as an investor is to build a reliably solid income stream for retirement, keeping quality dividend-paying stocks in your portfolio is essential.Since 1926, dividends have...
-
Johnson & Johnson: Reliable Defensive Blue-Chip Stock Continues Offering Upside
JNJ has made headway on cost reduction Shares are fairly expensive relative to trailing and expected earnings Wall Street consensus outlook is bullish Market-implied outlook is...
-
Market Review: Barclays, Mediclinic, Investec
SOUTH AFRICA MARKET REVIEW South African markets closed in the green yesterday, buoyed by broad based gains in retail and pharmaceutical sector stocks. Real estate property companies, Dipula...
-
Novavax Bulls: Benefit From Cash-Secured Puts On The Biotech's Beaten-Down Stock
Pre-commercial biotech group Novavax’s stock is down more than 45% in January. The FDA has not yet authorized Novavax’s vaccine for use in the US. Long-term investors could...
-
Dividends & Dividends
Market ScorecardYesterday, US markets endured another very volatile trading day and ended down. The S&P 500 staged a lunch-time recovery, turning green for a moment and erasing a 3% drop...
-
All Eyes on Fed Interest Rate Decision Tonight
Investors will eye the announcement from the US Federal Reserve (Fed) tonight to discern how aggressively this central bank will hike interest rates this year. The Fed’s latest dot...
-
1 Stock To Buy, 1 To Dump When Markets Open: McDonald’s, Robinhood
Stocks on Wall Street plunged in risk-off trade on Friday, with the NASDAQ Composite suffering its worst weekly loss since 2020, pushing the tech-heavy index further into correction...
-
US 4Q21 Earnings Season Storms Ahead
Locally, we expect the following company releases next week: The {{erl-8731||Anglo American (JO:AMSJ) stable will publish 4Q21 production numbers next week. Anglo American updated its FY21...
-
Rand "Likely to Remain Under Pressure During 2022"
Gazing into our crystal ball for the rand in 2022, the COVID-19 Omicron variant remains a significant unknown in the market.The variant is proving to be more transmissible but less severe...
-
2021 Year In Review: Investing.com Comic Edition
Compiled by Jesse CohenWith just one trading day left this year, Wall Street’s major indices are on track to close 2021 at record highs as optimism over the global economy appears to have...
-
9 ETFs For Exposure To Energy, Financials, And Healthcare Sectors
Investing in any of the 11 sectors of the S&P 500 index could help anyone diversify their portfolio. Yesterday, we discussed using exchange traded funds (ETFs) to gain a stake in three...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
